Why Compare Wegovy vs Mounjaro vs Ozempic Dose Options?
Wegovy vs Mounjaro vs Ozempic: Complete Dose Range Comparison
When evaluating Wegovy vs Mounjaro vs Ozempic, understanding the complete dosing journey is crucial for long-term treatment planning. Wegovy offers five distinct doses (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg) with mandatory monthly escalation to minimise gastrointestinal side effects whilst optimising efficacy. Mounjaro follows a similar escalation pattern but uses tirzepatide's dual hormone approach, targeting both GLP-1 and GIP receptors simultaneously. Ozempic, whilst containing the same semaglutide as Wegovy, remains licensed exclusively for type 2 diabetes management in the UK. EverydayMeds stocks every Wegovy dose, ensuring patients never face treatment interruptions due to supply shortages at different pharmacies.
The commitment to stocking all doses reflects our understanding that weight management requires consistent, long-term support rather than short-term solutions. Unlike pharmacies that may only stock popular doses, our comprehensive inventory means your 16-week dose escalation period progresses smoothly from £79.99 starter doses through to £209.99 maintenance therapy. This complete supply chain approach eliminates the common frustration of patients needing to source different doses from multiple providers, potentially compromising treatment continuity.
Wegovy vs Mounjaro vs Ozempic: Pricing Structure for Every Treatment Stage
Comparing Wegovy vs Mounjaro vs Ozempic pricing requires understanding both individual dose costs and long-term financial commitment. Our Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for 2.4mg maintenance therapy. New customers benefit from discount code FIRST40 applied at checkout, whilst returning patients use DOSE25 for continued savings. Our bundle options, including the Intro Duo (0.25mg & 0.5mg for £169.99) and Ultimate Stability Trio (three months of 2.4mg maintenance for £649.99), provide convenient multi-dose packages.
The financial consideration when comparing Wegovy vs Mounjaro vs Ozempic extends beyond single pen prices to long-term maintenance costs. Wegovy's 2.4mg maintenance dose at £209.99 represents the ongoing monthly investment for continued weight management support. Our bundle pricing strategy focuses on convenience rather than savings – ensuring Reliable Supply availability and reduced ordering frequency. With Ozempic being unsuitable for weight management licensing, the practical comparison centres on Wegovy's established semaglutide profile versus Mounjaro's newer dual-hormone mechanism.
Clinical Evidence: Wegovy vs Mounjaro vs Ozempic Trial Data
The clinical evidence supporting Wegovy vs Mounjaro vs Ozempic varies significantly due to different licensing indications and trial populations. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial demonstrated sustained weight loss of approximately 15.2% at 2 years, supporting long-term maintenance benefits.
Mounjaro's SURMOUNT trials showed promising results with tirzepatide's dual GIP and GLP-1 receptor targeting, though direct head-to-head comparisons with Wegovy remain limited due to different trial designs and populations. Ozempic's evidence base focuses on glycaemic control in diabetes rather than weight management outcomes, making direct comparison inappropriate for weight management purposes.
How Wegovy Works: GLP-1 Mechanism in Wegovy vs Mounjaro vs Ozempic
Understanding the mechanism differences in Wegovy vs Mounjaro vs Ozempic helps inform treatment decisions alongside clinical assessment. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone responsible for post-meal satiety signals. This mechanism reduces appetite by acting on brain appetite centres, promotes feelings of fullness after smaller meals, and may help reduce food cravings throughout the day. The once-weekly injection via FlexTouch pen provides consistent hormone levels, supporting sustained appetite regulation when used alongside a reduced-calorie diet and increased physical activity.
Ordering Process: Accessing Wegovy vs Mounjaro vs Ozempic Through EverydayMeds
The ordering process for comparing Wegovy vs Mounjaro vs Ozempic begins with our 3-minute online clinical assessment, designed to evaluate suitability based on MHRA licensing criteria including BMI requirements and weight-related comorbidities. Following assessment submission, our prescribers review applications within standard 3 working days (or 24 hours with express service), ensuring thorough clinical evaluation rather than automated approval systems. Once approved, all doses dispatch via next-day delivery using cold-chain temperature-controlled packaging, maintaining the 2-8°C storage requirements essential for semaglutide stability. Our GPhC-registered pharmacy status (#9012878) ensures all Wegovy supplies meet UK regulatory standards for prescription-only medicines.
Storage and Practical Considerations: Wegovy vs Mounjaro vs Ozempic
Storage requirements differ significantly when comparing Wegovy vs Mounjaro vs Ozempic, influencing practical treatment decisions for many patients. Wegovy offers superior storage flexibility with 6 weeks room temperature tolerance (below 30°C) once removed from refrigerated storage, compared to Mounjaro's 21-day limit. This storage advantage proves particularly valuable for travel, work commitments, or situations where refrigerated storage becomes temporarily unavailable. The FlexTouch pen design ensures accurate dose delivery throughout the escalation schedule, from 0.25mg starter doses through to 2.4mg maintenance therapy, with clear dose selection windows preventing administration errors.
Long-term Supply Strategy: Why All Doses Matter for Wegovy vs Mounjaro vs Ozempic
The importance of comprehensive dose availability becomes apparent when considering the 16-week escalation period required for Wegovy treatment optimisation. Many patients experience supply disruptions when pharmacies stock only popular doses, forcing treatment interruptions or pharmacy changes mid-escalation. Our commitment to stocking every Wegovy dose eliminates this concern, providing seamless progression from starter therapy through to long-term maintenance.
This comprehensive supply approach particularly benefits patients requiring slower dose escalation or those who need to repeat specific doses due to tolerability concerns. Rather than risking treatment discontinuation due to supply gaps, patients can maintain consistent therapy with one trusted pharmacy throughout their weight management journey. The convenience extends beyond individual patient needs to prescriber confidence, knowing their patients can access every prescribed dose without supply-related complications.
Making Your Choice: Wegovy vs Mounjaro vs Ozempic Next Steps
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns with your individual clinical profile and weight management goals. The decision between these prescription-only medicines involves multiple factors including medical history, previous treatment responses, and practical considerations like storage requirements and injection frequency. Our clinical team provides ongoing support throughout treatment, from initial assessment through dose escalation to maintenance therapy, ensuring continuity of care regardless of which treatment proves most suitable. Start your clinical assessment today using discount code FIRST40 for new customers, or DOSE25 for returning patients, and discover which option may best support your weight management journey alongside diet and exercise modifications at https://everydaymeds.co.uk/collections/wegovy.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
